Importer of Controlled Substances Application: Sigma Aldrich Co., LLC, 60903-60904 [2018-25867]
Download as PDF
60903
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
Controlled substance
Drug code
Phencyclidine .............................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) ...............................................................................................................
Phenylacetone ............................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ...........................................................................................................................
Cocaine ......................................................................................................................................................................
Codeine ......................................................................................................................................................................
Etorphine HCl .............................................................................................................................................................
Dihydrocodeine ..........................................................................................................................................................
Oxycodone .................................................................................................................................................................
Hydromorphone ..........................................................................................................................................................
Ecgonine ....................................................................................................................................................................
Ethylmorphine ............................................................................................................................................................
Hydrocodone ..............................................................................................................................................................
Levomethorphan ........................................................................................................................................................
Levorphanol ................................................................................................................................................................
Isomethadone .............................................................................................................................................................
Meperidine ..................................................................................................................................................................
Meperidine intermediate-B .........................................................................................................................................
Methadone .................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ........................................................................................................
Morphine ....................................................................................................................................................................
Thebaine ....................................................................................................................................................................
Oxymorphone .............................................................................................................................................................
Thiafentanil .................................................................................................................................................................
Alfentanil .....................................................................................................................................................................
Remifentanil ...............................................................................................................................................................
Sufentanil ...................................................................................................................................................................
Carfentanil ..................................................................................................................................................................
Tapentadol .................................................................................................................................................................
Fentanyl ......................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances to produce forensic and
research analytical reference standards
for distribution to its customers.
issuance of the proposed registration on
or before December 27, 2018. Such
persons may also file a written request
for a hearing on the application on or
before December 27, 2018.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
ADDRESSES:
[FR Doc. 2018–25865 Filed 11–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration
Importer of Controlled Substances
Application: Sigma Aldrich Co., LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
SUPPLEMENTARY INFORMATION:
amozie on DSK3GDR082PROD with NOTICES1
Jkt 247001
PO 00000
Frm 00083
Fmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug code
Cathinone ................................................................................................................................................................
Methcathinone .........................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
Aminorex .................................................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................
17:45 Nov 26, 2018
7471
8333
8501
8603
9041
9050
9059
9120
9143
9150
9180
9190
9193
9210
9220
9226
9230
9233
9250
9273
9300
9333
9652
9729
9737
9739
9740
9743
9780
9801
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
February 21, 2018, Sigma Aldrich Co.,
LLC, 3500 Dekalb Street, Saint Louis,
Missouri 63118 applied to be registered
as an importer of the following basic
classes of controlled substances:
Controlled substance
VerDate Sep<11>2014
Schedule
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
1235
1237
1248
1585
2010
2565
7249
7260
7315
Schedule
I
I
I
I
I
I
I
I
I
60904
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
Controlled substance
Drug code
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Mescaline ................................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
Bufotenine ...............................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocyn ...................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
N-Benzylpiperazine .................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
Heroin ......................................................................................................................................................................
Normorphine ............................................................................................................................................................
Etonitazene ..............................................................................................................................................................
Amobarbital .............................................................................................................................................................
Secobarbital .............................................................................................................................................................
Glutethimide ............................................................................................................................................................
Nabilone ..................................................................................................................................................................
Phencyclidine ..........................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................
Levorphanol .............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Thebaine ..................................................................................................................................................................
Opium, powdered ....................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
and 7370, the company plans to import
a synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other
activities for these drug codes are
authorized for this registration.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–25867 Filed 11–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
amozie on DSK3GDR082PROD with NOTICES1
[OMB Number 1121–NEW]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Approval of a
New Collection; Comments Requested:
National Survey of Victim Service
Providers (NSVSP)
Bureau of Justice Statistics,
Department of Justice.
ACTION: 30-Day Notice.
AGENCY:
The Department of Justice
(DOJ), Office of Justice Programs,
SUMMARY:
VerDate Sep<11>2014
17:45 Nov 26, 2018
Jkt 247001
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at Volume 83, Number 136,
page 32908, July 16, 2018, allowing for
a 60 day comment period.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 27, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Barbara Oudekerk, Statistician, Bureau
of Justice Statistics, 810 Seventh Street
NW, Washington, DC 20531 (email:
Barbara.a.oudekerk@usdoj.gov;
telephone: 202–616–3904).
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
7360
7370
7381
7391
7392
7395
7396
7400
7402
7404
7405
7411
7433
7434
7435
7438
7470
7493
7535
9200
9313
9624
2125
2315
2550
7379
7471
9170
9180
9190
9220
9230
9333
9639
9648
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
New collection.
E:\FR\FM\27NON1.SGM
27NON1
Agencies
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Pages 60903-60904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25867]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[Docket No. DEA-392]
Drug Enforcement Administration
Importer of Controlled Substances Application: Sigma Aldrich Co.,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before December 27, 2018.
Such persons may also file a written request for a hearing on the
application on or before December 27, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
February 21, 2018, Sigma Aldrich Co., LLC, 3500 Dekalb Street, Saint
Louis, Missouri 63118 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone....................... 1235 I
Methcathinone................... 1237 I
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
Aminorex........................ 1585 I
Gamma Hydroxybutyric Acid....... 2010 I
Methaqualone.................... 2565 I
Alpha-ethyltryptamine........... 7249 I
Ibogaine........................ 7260 I
Lysergic acid diethylamide...... 7315 I
[[Page 60904]]
Marihuana....................... 7360 I
Tetrahydrocannabinols........... 7370 I
Mescaline....................... 7381 I
4-Bromo-2,5-dimethoxyamphetamine 7391 I
4-Bromo-2,5- 7392 I
dimethoxyphenethylamine.
4-Methyl-2,5- 7395 I
dimethoxyamphetamine.
2,5-Dimethoxyamphetamine........ 7396 I
3,4-Methylenedioxyamphetamine... 7400 I
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4- 7405 I
Methylenedioxymethamphetamine.
4-Methoxyamphetamine............ 7411 I
Bufotenine...................... 7433 I
Diethyltryptamine............... 7434 I
Dimethyltryptamine.............. 7435 I
Psilocyn........................ 7438 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine.............. 7493 I
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
Heroin.......................... 9200 I
Normorphine..................... 9313 I
Etonitazene..................... 9624 I
Amobarbital..................... 2125 II
Secobarbital.................... 2315 II
Glutethimide.................... 2550 II
Nabilone........................ 7379 II
Phencyclidine................... 7471 II
Diphenoxylate................... 9170 II
Ecgonine........................ 9180 II
Ethylmorphine................... 9190 II
Levorphanol..................... 9220 II
Meperidine...................... 9230 II
Thebaine........................ 9333 II
Opium, powdered................. 9639 II
Levo-alphacetylmethadol......... 9648 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis. In reference
to drug codes 7360 and 7370, the company plans to import a synthetic
cannabidiol and a synthetic tetrahydrocannabinol. No other activities
for these drug codes are authorized for this registration.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-25867 Filed 11-26-18; 8:45 am]
BILLING CODE 4410-09-P